<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis - Georgiou, EX - 2019 | Cochrane Library</title> <meta content="Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis - Georgiou, EX - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013240.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis - Georgiou, EX - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013240.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013240.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis" name="citation_title"/> <meta content="Ektoras X Georgiou" name="citation_author"/> <meta content="Buckinghamshire Hospitals NHS Trust" name="citation_author_institution"/> <meta content="hgeorgiou@gmail.com" name="citation_author_email"/> <meta content="Pedro Melo" name="citation_author"/> <meta content="Buckinghamshire Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Philip E Baker" name="citation_author"/> <meta content="Oxford University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Hassan N Sallam" name="citation_author"/> <meta content="Alexandria University" name="citation_author_institution"/> <meta content="Aydin Arici" name="citation_author"/> <meta content="Yale University" name="citation_author_institution"/> <meta content="Juan A Garcia‐Velasco" name="citation_author"/> <meta content="IVI Madrid" name="citation_author_institution"/> <meta content="Ahmed M Abou‐Setta" name="citation_author"/> <meta content="University of Manitoba" name="citation_author_institution"/> <meta content="Christian Becker" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Ingrid E Granne" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD013240.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/11/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013240.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013240.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013240.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Fertilization in Vitro; *Pregnancy Rate; Abortion, Spontaneous [epidemiology]; Endometriosis [*physiopathology]; Gonadotropins [*agonists]; Infertility, Female [etiology, *therapy]; Ovulation Induction; Pregnancy Outcome; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013240.pub2&amp;doi=10.1002/14651858.CD013240.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6iOnQIUh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013240\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013240\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","th","ms","fa","fr","ko","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013240.pub2",title:"Long\\u2010term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis",firstPublishedDate:"Nov 20, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6iOnQIUh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013240.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013240.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013240.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013240.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013240.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013240.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013240.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013240.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013240.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013240.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11411 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013240.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0118"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0069"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-sec-0112"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/appendices#CD013240-sec-0123"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/table_n/CD013240StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/table_n/CD013240StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ektoras X Georgiou</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0003">Pedro Melo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0004">Philip E Baker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0005">Hassan N Sallam</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0006">Aydin Arici</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0007">Juan A Garcia‐Velasco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0008">Ahmed M Abou‐Setta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0009">Christian Becker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information#CD013240-cr-0010">Ingrid E Granne</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information/en#CD013240-sec-0131">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 November 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013240.pub2">https://doi.org/10.1002/14651858.CD013240.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013240-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013240-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013240-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013240-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013240-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013240-abs-0013">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD013240-abs-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013240-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013240-abs-0001" lang="en"> <section id="CD013240-sec-0001"> <h3 class="title" id="CD013240-sec-0001">Background</h3> <p>Endometriosis is known to have an impact on fertility and it is common for women affected by endometriosis to require fertility treatments, including in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI), to improve the chance of pregnancy. It has been postulated that long‐term gonadotrophin‐releasing hormone (GnRH) agonist therapy prior to IVF or ICSI can improve pregnancy outcomes. This systematic review supersedes the previous Cochrane Review on this topic (<a href="http://Sallam 2006" target="_blank">Sallam 2006</a>). </p> </section> <section id="CD013240-sec-0002"> <h3 class="title" id="CD013240-sec-0002">Objectives</h3> <p>To determine the effectiveness and safety of long‐term gonadotrophin‐releasing hormone (GnRH) agonist therapy (minimum 3 months) versus no pretreatment or other pretreatment modalities, such as long‐term continuous combined oral contraception (COC) or surgical therapy of endometrioma, before standard in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) in women with endometriosis. </p> </section> <section id="CD013240-sec-0003"> <h3 class="title" id="CD013240-sec-0003">Search methods</h3> <p>We searched the following electronic databases from their inception to 8 January 2019: Cochrane Gynaecology and Fertility Specialised Register of Controlled Trials, CENTRAL via the Cochrane CENTRAL Register of Studies ONLINE (CRSO), MEDLINE, Embase, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL). We searched trial registries to identify unpublished and ongoing trials. We also searched DARE (Database of Abstracts of Reviews of Effects), Web of Knowledge, OpenGrey, Latin American and Caribbean Health Science Information Database (LILACS), PubMed, Google and reference lists from relevant papers for any other relevant trials. </p> </section> <section id="CD013240-sec-0004"> <h3 class="title" id="CD013240-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) involving women with surgically diagnosed endometriosis that compared use of any type of GnRH agonist for at least three months before an IVF/ICSI protocol to no pretreatment or other pretreatment modalities, specifically use of long‐term continuous COC (minimum of 6 weeks) or surgical excision of endometrioma within six months prior to standard IVF/ICSI. The primary outcomes were live birth rate and complication rate per woman randomised. </p> </section> <section id="CD013240-sec-0005"> <h3 class="title" id="CD013240-sec-0005">Data collection and analysis</h3> <p>Two independent review authors assessed studies against the inclusion criteria, extracted data and assessed risk of bias. A third review author was consulted, if required. We contacted the study authors, as required. We analysed dichotomous outcomes using Mantel‐Haenszel risk ratios (RRs), 95% confidence intervals (CIs) and a fixed‐effect model. For small numbers of events, we used a Peto odds ratio (OR) with 95% CI instead. We analysed continuous outcomes using the mean difference (MD) between groups and presented with 95% CIs. We studied heterogeneity of the studies via the I<sup>2</sup> statistic. We assessed the quality of evidence using GRADE criteria. </p> </section> <section id="CD013240-sec-0006"> <h3 class="title" id="CD013240-sec-0006">Main results</h3> <p>We included eight parallel‐design RCTs, involving a total of 640 participants. We did not assess any of the studies as being at low risk of bias across all domains, with the main limitation being lack of blinding. Using GRADE methodology, the quality of the evidence ranged from very low to low quality. </p> <p><b>Long‐term GnRH agonist therapy versus no pretreatment</b> </p> <p>We are uncertain whether long‐term GnRH agonist therapy affects the live birth rate (RR 0.48, 95% CI 0.26 to 0.87; 1 RCT, n = 147; I<sup>2</sup> not calculable; very low‐quality evidence) or the overall complication rate (Peto OR 1.23, 95% CI 0.37; to 4.14; 3 RCTs, n = 318; I<sup>2</sup> = 73%; very low‐quality evidence) compared to standard IVF/ICSI. Further, we are uncertain whether this intervention affects the clinical pregnancy rate (RR 1.13, 95% CI 0.91 to 1.41; 6 RCTs, n = 552, I<sup>2</sup> = 66%; very low‐quality evidence), multiple pregnancy rate (Peto OR 0.14, 95% CI 0.03 to 0.56; 2 RCTs, n = 208, I<sup>2</sup> = 0%; very low‐quality evidence), miscarriage rate (Peto OR 0.45, 95% CI 0.10 to 2.00; 2 RCTs, n = 208; I<sup>2</sup> = 0%; very low‐quality evidence), mean number of oocytes (MD 0.72, 95% CI 0.06 to 1.38; 4 RCTs, n = 385; I<sup>2</sup> = 81%; very low‐quality evidence) or mean number of embryos (MD ‐0.76, 95% CI ‐1.33 to ‐0.19; 2 RCTs, n = 267; I<sup>2</sup> = 0%; very low‐quality evidence). </p> <p><b>Long‐term GnRH agonist therapy versus long‐term continuous COC</b> </p> <p>No studies reported on this comparison.</p> <p><b>Long‐term GnRH agonist therapy versus surgical therapy of endometrioma</b> </p> <p>No studies reported on this comparison.</p> </section> <section id="CD013240-sec-0007"> <h3 class="title" id="CD013240-sec-0007">Authors' conclusions</h3> <p>This review raises important questions regarding the merit of long‐term GnRH agonist therapy compared to no pretreatment prior to standard IVF/ICSI in women with endometriosis. Contrary to previous findings, we are uncertain as to whether long‐term GnRH agonist therapy impacts on the live birth rate or indeed the complication rate compared to standard IVF/ICSI. Further, we are uncertain whether this intervention impacts on the clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, mean number of oocytes and mean number of embryos. In light of the paucity and very low quality of existing data, particularly for the primary outcomes examined, further high‐quality trials are required to definitively determine the impact of long‐term GnRH agonist therapy on IVF/ICSI outcomes, not only compared to no pretreatment, but also compared to other proposed alternatives to endometriosis management. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013240-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013240-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013240-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013240-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013240-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013240-abs-0014">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013240-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD013240-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013240-abs-0016">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013240-abs-0007">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013240-abs-0006" lang="en"> <h3>Long‐term pituitary down‐regulation before in vitro fertilisation (IVF) for women with endometriosis </h3> <p><b>Review question</b> </p> <p>We reviewed the efficacy and safety of treating women with known endometriosis (a disease characterised by the presence of endometrial tissue outside the cavity of the womb) with gonadotrophin‐releasing hormone (GnRH) agonist medication for a period of three to six months prior to in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). We aimed to compare this intervention to no treatment prior to IVF/ICSI, pretreatment with long‐term continuous combined oral contraception (COC) or surgical treatment to remove endometriomas (cysts forming in the ovaries as a consequence of endometriosis). </p> <p><b>Background</b> </p> <p>Many women affected by endometriosis suffer with infertility and may, as a result, seek IVF/ICSI treatment. IVF/ICSI is known to be less successful in women with endometriosis and a variety of interventions prior to IVF/ICSI have been proposed to try and improve outcomes. These include long‐term GnRH agonist therapy, long‐term continuous COC therapy or surgery to remove endometriomas. </p> <p><b>Study characteristics</b> </p> <p>We found eight randomised controlled trials comparing long‐term GnRH agonist therapy with no pretreatment including a total of 640 women with endometriosis prior to IVF/ICSI. The evidence is current to January 2019. </p> <p><b>Key results</b> </p> <p>Compared to no pretreatment, we are uncertain whether long‐term GnRH agonist therapy prior to IVF/ICSI in women with endometriosis affects the live birth rate. The evidence suggests that if the chance of live birth rate is assumed to be 36% with no pretreatment, the chance following long‐term GnRH agonist therapy would be between 9% and 31%. We are also uncertain whether this intervention affects complication rate, clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, mean number of oocytes and mean number of embryos. No studies compared long‐term GnRH agonist therapy to long‐term continuous COC therapy or surgery to remove endometriomas. </p> <p><b>Quality of the evidence</b> </p> <p>The evidence was of very low quality. The main limitations in the evidence were lack of blinding (the process where the women participating in the trial, as well as the research staff, are not aware of the intervention used), inconsistency (differences between different studies) and imprecision (random error and small size of each study). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013240-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013240-sec-0118"></div> <h3 class="title" id="CD013240-sec-0119">Implications for practice</h3> <section id="CD013240-sec-0119"> <p>This review raises important questions regarding the merit of long‐term gonadotrophin‐releasing hormone (GnRH) agonist therapy compared to no pretreatment prior to standard vitro fertilisation/intracytoplasmic sperm injection(IVF/ICSI) in women with endometriosis. Contrary to previous findings, we are uncertain as to whether long‐term GnRH agonist therapy impacts on the live birth rate or indeed the complication rate compared to standard IVF/ICSI. Further, we are uncertain whether this intervention impacts on the clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, mean number of oocytes and mean number of embryos. In light of the paucity and very low quality of existing data, particularly for the primary outcomes examined, further high‐quality trials are required to definitively determine the impact of long‐term GnRH agonist therapy on IVF/ICSI outcomes, not only compared to no pretreatment, but also compared to other proposed alternatives to endometriosis management. </p> </section> <h3 class="title" id="CD013240-sec-0120">Implications for research</h3> <section id="CD013240-sec-0120"> <p>More high‐quality RCTs are needed to definitively address the questions of efficacy and safety of long‐term GnRH agonist therapy before IVF/ICSI in women with endometriosis. Specifically, we suggest that future studies need to focus on live birth rate and complication rate as the primary outcomes of choice. In addition, study design to address the comparison of long‐term GnRH agonist therapy versus no pretreatment will need to be improved by consistent blinding in terms of participants, personnel and outcome assessors. This will also ensure that the time frame between initiation of IVF/ICSI is the same in both groups, i.e. the control group does not potentially progress to IVF/ICSI sooner after the immediate postoperative period than the GnRH agonist group. We would also advocate for further studies specifically examining the effect of fresh versus cryopreserved embryo transfer following long‐term GnRH agonist therapy. This is on the basis of retrospective data suggesting outcomes, including clinical pregnancy and live birth, are improved with cryopreserved embryo transfer following GnRH agonist therapy in women with endometriosis (<a href="./references#CD013240-bbs2-0065" title="MohamedAM , ChouliarasS , JonesCJ , NardoLG . Live birth rate in fresh and frozen embryo transfer cycles in women with endometriosis. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;156(2):177‐80. ">Mohamed 2011</a>; <a href="./references#CD013240-bbs2-0084" title="XieD , ChenF , XieSZ , ChenZL , TuoP , ZhouR , et al. Artificial cycle with or without a depot gonadotropin‐releasing hormone agonist for frozen‐thawed embryo transfer: an assessment of infertility type that is most suitable. Current Medical Science2018;38(4):626‐31. ">Xie 2018</a>). </p> <p>Given the lack of RCTs comparing long‐term GnRH agonist therapy to other pretreatments prior to standard IVF/ICSI, these will need to be conducted. It would also be interesting for future studies to examine outcomes following continuous combined oral contraception (COC) therapy or surgical excision of endometrioma as compared to standard IVF/ICSI. In addition, in terms of basic science, it would be interesting to study the effect of long‐term GnRH agonist therapy on oocyte and/or embryo quality. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013240-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013240-sec-0036"></div> <div class="table" id="CD013240-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard IVF/ICSI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with endometriosis prior to standard IVF/ICSI<br/> <b>Setting:</b> assisted reproduction clinic<br/> <b>Intervention:</b> long‐term GnRH agonist therapy<br/> <b>Comparison:</b> no additional therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no additional therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with long‐term GnRH agonist therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.48<br/> (0.26 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>147<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on live birth rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>355 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1000<br/> (92 to 309) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Complication rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Peto OR 1.23<br/> (0.37 to 4.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>318<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on complication rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1000<br/> (11 to 128) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical pregnancy rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/> (0.91 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>552<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on clinical pregnancy rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>331 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>374 per 1000<br/> (301 to 467) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multiple pregnancy rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Peto OR 0.14<br/> (0.04 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>208<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on multiple pregnancy rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (3 to 41) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Peto OR 0.45<br/> (0.10 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>208<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>b,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on miscarriage rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000<br/> (5 to 93) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of oocytes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of oocytes was 8.43</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.72 higher<br/> (0.06 higher to 1.38 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>385<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on mean number of oocytes. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of embryos</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of embryos was 4.74</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.76 lower<br/> (1.33 lower to 0.19 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>267<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,e,h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on mean number of embryos. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>GnRH</b> : gonadotrophin‐releasing hormone; <b>IVF/ICSI</b> : in vitro fertilisation/intracytoplasmic sperm injection; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> data arising exclusively from an unpublished trial; downgraded one level. </p> <p><sup>b</sup> small number of events; downgraded two levels. </p> <p><sup>c</sup> incorporates at least one open‐label study; downgraded one level. </p> <p><sup>d</sup> high degree of heterogeneity; downgraded one level. </p> <p><sup>e</sup> wide confidence intervals; downgraded one level. </p> <p><sup>f</sup> data arising from an unpublished trial and a conference abstract; downgraded one level. </p> <p><sup>g</sup> very high degree of heterogeneity; downgraded two levels. </p> <p><sup>h</sup> significant contribution by an unpublished trial; downgraded one level. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013240-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013240-sec-0037"></div> <section id="CD013240-sec-0038"> <h3 class="title" id="CD013240-sec-0038">Description of the condition</h3> <p>Endometriosis is a challenging disease observed in 16% to 50% of infertile women (<a href="./references#CD013240-bbs2-0058" title="HartR . Unexplained infertility. Endometriosis and fibroids. BMJ2003;27:721‐4. ">Hart 2003</a>; <a href="./references#CD013240-bbs2-0064" title="MeulemanC , VandenabeeleB , FieuwsS , SpiessensC , TimmermanD , D'HoogheT . High prevalence of endometriosis in infertile women with normal ovulation and normosperm partners. Fertility and Sterility2009;92:64‐74. ">Meuleman 2009</a>; <a href="./references#CD013240-bbs2-0073" title="PrescottJ , FarlandLV , TobiasDK , GaskinsAJ , SpiegelmanD , ChavarroJE , et al. A prospective cohort study of endometriosis and subsequent risk of infertility. Human Reproduction2016;31(7):1475‐82. ">Prescott 2016</a>; <a href="./references#CD013240-bbs2-0086" title="ZondervanKT , BeckerCM , KogaK , MissmerSA , TaylorRN , ViganòP . Endometriosis. Nature Reviews Disease Primers2018;4(1):9. ">Zondervan 2018</a>). A cause and effect relationship between endometriosis and infertility has not been established, but it has been postulated that a combination of distorted pelvic anatomy, altered peritoneal function, alteration of immunological milieu within the peritoneal cavity, diminished ovarian reserve and altered endometrial receptivity could be the cause of infertility (<a href="./references#CD013240-bbs2-0040" title="The Practice Committee of the American Society of Reproductive Medicine. Endometriosis and infertility. Fertility and Sterility2006;86(4):S156‐60. ">ASRM 2006</a>; <a href="./references#CD013240-bbs2-0052" title="GuidiceLC . Clinical practice. Endometriosis. New England Journal of Medicine2010;362:2389‐98. ">Giudice 2010</a>). Women with endometriosis often require in vitro fertilisation (IVF) to improve the chance of pregnancy, and more than one‐third of women undergoing IVF have endometriosis (<a href="./references#CD013240-bbs2-0071" title="OzkanS , MurkW , AriciA . Endometriosis and Infertility: epidemiology and evidence‐based treatments. Annals of New York Academy of Sciences2008;1127:92‐100. ">Ozkan 2008</a>). The benefits of in vitro fertilisation‐embryo transfer (IVF‐ET) in endometriosis‐associated infertility are well established (<a href="./references#CD013240-bbs2-0042" title="BanhartK , Dunsmoore‐SuR , CoutifarisC . Effect of endometriosis on in vitro fertilization. Fertility and Sterility2002;77(6):1148‐55. ">Barnhart 2002</a>; <a href="./references#CD013240-bbs2-0069" title="OlivennesF . Result of IVF in women with endometriosis. Journal of Gynaecology Obstetrics and Biology of Reproduction2003;32:547‐7. ">Olivennes 2003</a>; <a href="./references#CD013240-bbs2-0070" title="OpoeinHO , PeterF , AnneKO , ThomasA , SveereB , GudvorE . In vitro fertilization is a successful treatment in endometriosis‐associated infertility. Fertility and Sterility2012;97(4):913‐8. ">Opoein 2012</a>). A meta‐analysis of 22 non‐randomised studies on the effect of endometriosis on IVF outcomes concluded that endometriosis interferes with all aspects of the reproductive process and is associated with lower success rates than other indications for IVF (<a href="./references#CD013240-bbs2-0042" title="BanhartK , Dunsmoore‐SuR , CoutifarisC . Effect of endometriosis on in vitro fertilization. Fertility and Sterility2002;77(6):1148‐55. ">Barnhart 2002</a>). The overall chance of achieving pregnancy with IVF in these 22 studies was 25%. Nevertheless, a fairly recent large retrospective cohort study of 2245 women reported comparable pregnancy rates and live birth rates of IVF/intracytoplasmic sperm injection (ICSI) treatment in women with endometriosis‐related infertility as in women with tubal factors, except for those with ovarian endometrioma (<a href="./references#CD013240-bbs2-0070" title="OpoeinHO , PeterF , AnneKO , ThomasA , SveereB , GudvorE . In vitro fertilization is a successful treatment in endometriosis‐associated infertility. Fertility and Sterility2012;97(4):913‐8. ">Opoein 2012</a>). </p> <p>The severity of endometriosis has been shown to have a direct impact on the outcomes of IVF/ICSI treatment (<a href="./references#CD013240-bbs2-0041" title="AzemF , LessingJB , GevaA , ShaharA , Lerner‐GevaL . Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization‐embryo transfer than patients with tubal infertility. Fertility and Sterility1999;72(6):1107‐9. ">Azem 1999</a>; <a href="./references#CD013240-bbs2-0045" title="CocciaME , RizzelloF , MarianiG , BullettiC , PalagianoA , ScarselliG . Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage‐dependent interference. Acta Obstetricia et Gynecologica Scandinavica2011;90(11):1232‐8. ">Coccia 2011</a>; <a href="./references#CD013240-bbs2-0069" title="OlivennesF . Result of IVF in women with endometriosis. Journal of Gynaecology Obstetrics and Biology of Reproduction2003;32:547‐7. ">Olivennes 2003</a>). A recent meta‐analysis of 27 non‐randomised studies reported a slight reduction in fertilisation rates among women with ASRM (American Society of Reproductive Medicine) stage I/II endometriosis undergoing IVF/ICSI treatment (risk ratio (RR) 0.93, 95% confidence interval (CI) 0.87 to 0.99, P = 0.03; (<a href="./references#CD013240-bbs2-0055" title="HarbHM , GallosID , ChuJ , HarbM , CoomarasamyA . The effect of endometriosis on in vitro fertilization outcome: a systematic review and meta‐analysis. BJOG2013;120:1308‐20. ">Harb 2013</a>). In women with severe pelvic endometriosis and stage III/IV disease, implantation rates were significantly reduced (RR 0.79, 95% CI 0.67 to 0.93, P = 0.006), as were clinical pregnancy rates (RR 0.76, 95% CI 0.69 to 0.91, P = 0.0008). In stage I/II disease, a hostile pelvic environment due to alteration of immunological milieu within the peritoneal cavity may be responsible for impaired gamete and early embryo development (<a href="./references#CD013240-bbs2-0075" title="RyanIP , TaylorRN . Endometriosis and infertility: new concept. Obstetrical and Gynaecological Survey1997;52:365‐71. ">Ryan 1997</a>; <a href="./references#CD013240-bbs2-0077" title="SurreyES , HalmeJ . Effect of peritoneal fluid from endometriosis patient on endometrial stromal cell proliferation in vitro. Obstetrics and Gynaecology1990;76:792‐7. ">Surrey 1998</a>). On the other hand, in stage III/IV endometriosis, lower oocyte yield and poor oocyte quality (<a href="./references#CD013240-bbs2-0068" title="NorenstedtSN , Linderoth‐NagyC , BergendalA , SjoblomP , BergqvistA . Reduced developmental potential in oocytes from women with endometriosis. Journal of Assisted Reproduction and Genetics2001;18(12):644‐9. ">Norenstedt 2001</a>; <a href="./references#CD013240-bbs2-0072" title="PalL , ShifrenJL , IsaacsonKB , ChangY , TothTL . Impact of varying stages of endometriosis on the outcome of in vitro fertilisation and embryo transfer. Journal of Assisted Reproduction and Genetics1998;43:351‐2. ">Pal 1998</a>), resulting in embryos of lesser quality have been reported to be responsible for lower pregnancy and implantation rates post‐IVF/ICSI (<a href="./references#CD013240-bbs2-0039" title="AriciA , OralE , BukulmezO , DulebaA , OliveDL , JonesEE . The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program. Fertility and Sterility1996;65(3):603‐7. ">Arici 1996</a>; <a href="./references#CD013240-bbs2-0042" title="BanhartK , Dunsmoore‐SuR , CoutifarisC . Effect of endometriosis on in vitro fertilization. Fertility and Sterility2002;77(6):1148‐55. ">Barnhart 2002</a>). </p> </section> <section id="CD013240-sec-0039"> <h3 class="title" id="CD013240-sec-0039">Description of the intervention</h3> <p>The surgical management of asymptomatic ovarian endometrioma in women before IVF is debatable. A systematic review and meta‐analysis of 21 cohort studies (<a href="./references#CD013240-bbs2-0074" title="RaffiF , MetwallyM , AmerS . The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta‐analysis. Journal of Clinical Endocrinology and Metabolism2012;97(9):3146‐54. ">Raffi 2012</a>), and recent non‐randomised studies (<a href="./references#CD013240-bbs2-0080" title="TangY , ChenSL , ChenX , HeYX , YeDS , GuoW , et al. Ovarian damage after laparoscopic endometrioma excision might be related to the size of cyst. Fertility and Sterility2013;100(2):464‐9. ">Tang 2013</a>; <a href="./references#CD013240-bbs2-0082" title="UrmanB , AlperE , YakinK , OktemO , AksoyS , AlatasC , et al. Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve. Reproductive BioMedicine Online2013;27(2):212‐6. ">Urman 2013</a>), reported a negative impact of excision of endometriomas on ovarian reserve. Another systematic review of 20 non‐randomised studies (<a href="./references#CD013240-bbs2-0081" title="TsoumpouI , KyrgiouM , GelbayaTA , NardoLG . The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta‐analysis. Fertility and Sterility2009;92:75‐87. ">Tsoumpou 2009</a>), concluded that excision of endometriomas has no significant effect on IVF pregnancy rates and ovarian response to stimulation compared with no treatment, nor does it improve fertility outcomes (<a href="./references#CD013240-bbs2-0049" title="Garcia‐VelascoJA , MahutteMG , CoronaJ , ZunigaV , GilesJ , AriciA , et al. Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched case‐control study. Fertility and Sterility2004;81:1194‐7. ">Garcia‐Velasco 2004</a>; <a href="./references#CD013240-bbs2-0051" title="GeberS , FerreiraDP , Spyer PratesLF , SalesL , SampaioM . Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reproductive BioMedicine Online2002;5:162‐5. ">Geber 2002</a>; <a href="./references#CD013240-bbs2-0079" title="SuzukiT , IzumiS , MatsubayashiH , AwajiH , YoshikataK , MakinoT . Impact of ovarian endometrioma on oocytes and pregnancy outcome in in‐vitro fertilization. Fertility and Sterility2005;83(4):908‐13. ">Suzuki 2005</a>). On the other hand, non‐randomised studies have reported that resection of mild endometriosis and/or restoration of the pelvic anatomy (<a href="./references#CD013240-bbs2-0056" title="HärkkiP , TiitinenA , YlikorkalaO . Endometriosis and assisted reproduction techniques. Annals of the New York Academy of Sciences2010;1205:207‐13. ">Harkki 2010</a>; <a href="./references#CD013240-bbs2-0062" title="MarconiG , VilelaM , QuintanaR , SueldoC . Laparoscopic ovarian cystectomy of endometriomas does not affect the ovarian response to gonadotropin stimulation. Fertility and Sterility2002;78(4):876‐8. ">Marconi 2002</a>), especially if done laparoscopically, may enhance the efficacy of assisted reproductive techniques, but that aggressive ovarian surgery should be avoided. Because of the negative effect of surgical management of endometriosis on the ovarian reserve, pituitary suppression therapy with gonadotrophin‐releasing hormone (GnRH) agonists before IVF has become a popular alternative chosen by many clinicians. </p> <p>Long‐term therapy with GnRH agonists, synthetic peptide analogues of GnRH, has been shown to be effective in treating symptomatic endometriosis, including a reduction in the size of some endometriomas (<a href="./references#CD013240-bbs2-0078" title="SurreyES . Gonadotrophin‐releasing hormone agonists and add‐back therapy: what do the data show?. Current Opinion on Obstetrics and Gynaecology2010;22:283‐8. ">Surrey 2010a</a>). However, whether this improves fecundity is questionable. Several non‐randomised studies (<a href="./references#CD013240-bbs2-0019" title="MaC , QiaoJ , LiuP , ChenG . Ovarian suppression treatment prior to in‐vitro fertilization and embryo transfer in Chinese women with stage III or IV endometriosis. International Journal of Gynaecology and Obstetrics2008;100(2):167‐70. ">Ma 2008</a>; <a href="./references#CD013240-bbs2-0063" title="MarcusSF , EdwardsRG . High rates of pregnancy after long term down regulation of women with endometriosis. American Journal of Obstetrics and Gynaecology1994;171:812‐7. ">Marcus 1994</a>; <a href="./references#CD013240-bbs2-0067" title="NakamuraK , OosawaM , KondouI , IngakiS , ShibataH , NaritaO . Menotrophin stimulation after prolonged gonadotrophin releasing hormone agonist pretreatment for in‐vitro fertilization in patients with endometriosis. Journal of Assisted Reproduction and Genetics1992;9:113‐7. ">Nakamura 1992</a>; <a href="./references#CD013240-bbs2-0083" title="Van deHauvenLE , MijatovicV , LeemhiusE , SchatsR , HeymansMW , LambalkCB , et al. Efficacy &amp; safety of IVF/ICSI in patients with severe endometriosis after long term pituitary down regulation. Reproductive BioMedicine Online2013;28(1):39‐46. [http://www.rbmojournal.com/article/S1472‐6483(13)00523‐3/] ">Van der Hauven 2013</a>), suggest that in women with endometriosis‐related infertility, long‐term treatment with GnRH agonists for at least three months (and up to six months) before IVF cycles are initiated may improve implantation and clinical pregnancy rates and reduce preclinical miscarriages, compared with a conventional IVF protocol. GnRH agonists (leuprorelin, goserelin, buserelin, gonadorelin, triptorelin, nafarelin), depending on their formulation, can be given intramuscularly, subcutaneously or intranasally. Upon completion of GnRH treatment, approximately two to four weeks from the last administration, an ovarian stimulation protocol with gonadotrophins is initiated according to standard IVF/ICSI procedures. </p> </section> <section id="CD013240-sec-0040"> <h3 class="title" id="CD013240-sec-0040">How the intervention might work</h3> <p>Continuous hypophyseal exposure to GnRH agonists leads to down‐regulation of GnRH receptors, which desensitises the pituitary gland. The hypogonadotrophic‐hypogonadal state results in prolonged amenorrhoea and a low estradiol (E2) level, thus depriving existing endometriotic lesions of their main growth stimulus. This may improve the symptoms of endometriosis, and it is plausible that it may also reverse the negative effects of endometriosis on IVF cycles, including poor folliculogenesis resulting in oocytes of reduced quality; a hostile peritoneal environment from macrophages, cytokines or vasoactive substances in the peritoneal fluid; mechanical interference with oocyte pickup and transportation; and anatomical dysfunction of the fallopian tubes and ovaries (<a href="./references#CD013240-bbs2-0044" title="CahillDJ , WardlePG , HarlowCR , HullMG . Ovarian dysfunction in endometriosis‐associated and unexplained infertility. Journal of Assisted Reproduction and Genetics1997;14(10):554‐7. ">Cahill 1996</a>; <a href="./references#CD013240-bbs2-0055" title="HarbHM , GallosID , ChuJ , HarbM , CoomarasamyA . The effect of endometriosis on in vitro fertilization outcome: a systematic review and meta‐analysis. BJOG2013;120:1308‐20. ">Harb 2013</a>; <a href="./references#CD013240-bbs2-0057" title="HarlowCR , CahillDJ , MaileLA , TalbotMW , MearsJ , WardlePG . Reduced perovulatory granulosa cell steroidogenesis in women with endometriosis. Journal of Clinical Endocrinology and Metabolism1996;81:426‐9. ">Harlow 1996</a>). It has been suggested by several non‐randomised studies that poor oocyte quality results in decreased fertilisation rates (<a href="./references#CD013240-bbs2-0043" title="BergendalA , NaffahS , NagyC , BergqvistA , SjoblomP , HillensjoT . Outcome of IVF in patients with endometriosis in comparison with tubal‐factor infertility. Journal of Assisted Reproduction and Genetics1998;15(9):530‐4. ">Bergendal 1998</a>; <a href="./references#CD013240-bbs2-0050" title="GarridoN , NevarroJ , RemohiJ , SimonC , PellicerA . Follicular hormonal environment and embryo quality in women with endometriosis. Human Reproduction Update2000;6(1):67‐74. ">Garrido 2000</a>; <a href="./references#CD013240-bbs2-0072" title="PalL , ShifrenJL , IsaacsonKB , ChangY , TothTL . Impact of varying stages of endometriosis on the outcome of in vitro fertilisation and embryo transfer. Journal of Assisted Reproduction and Genetics1998;43:351‐2. ">Pal 1998</a>). This in turn leads to embryos of lesser quality, along with a reduced implantation rate, especially in severe endometriosis (<a href="./references#CD013240-bbs2-0039" title="AriciA , OralE , BukulmezO , DulebaA , OliveDL , JonesEE . The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program. Fertility and Sterility1996;65(3):603‐7. ">Arici 1996</a>; <a href="./references#CD013240-bbs2-0076" title="SimonC , GutierrezA , VidalA , de losSantosMJ , TarinJJ , RemohiJ , et al. Outcome of patients with endometriosis in assisted reproduction: results from in‐vitro fertilization and oocyte donation. Human Reproduction1994;9(4):725‐9. ">Simon 1994</a>). A higher rate of implantation and multiple pregnancy after ovarian stimulation has been reported in women in a hypogonadotrophic‐hypogonadal state (<a href="./references#CD013240-bbs2-0047" title="EdwardsRG . Clinical approaches to improving uterine receptivity during human implantation. Human Reproduction1995;10(S):60‐6. ">Edwards 1995</a>); this might be due to improved endometrial responsiveness following amenorrhoea. However, other studies have reported contradictory findings (<a href="./references#CD013240-bbs2-0054" title="HaouziD , AssouS , DechanelC , AnthonyT , DechaudS , deVosJ . Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in human: protocol effects. Biology of Reproduction2010;82:679‐83. ">Haouzi 2010</a>; <a href="./references#CD013240-bbs2-0059" title="HickmanTN . Impact of endometriosis on implantation. Data from the Wilford Hall Medical Centre IVF‐ET Program. Journal of Reproductive Medicine2002;47(10):801‐8. ">Hickman 2002</a>). </p> </section> <section id="CD013240-sec-0041"> <h3 class="title" id="CD013240-sec-0041">Why it is important to do this review</h3> <p>The previous version of this review suggested that long‐term GnRH agonist therapy before IVF/ICSI in women with endometriosis is associated with higher live birth and clinical pregnancy rates (<a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>). However, the live birth data were extrapolated from a single study reporting on pregnancies that "reached viability" (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>). Furthermore, the clinical pregnancy rate was calculated from meta‐analysis of three studies, of which two reported no significant difference (<a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>), but with the data reaching statistical significance due to the size of the effect reported by <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>. </p> <p>Based on the findings of <a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>, IVF/ICSI with long‐term pituitary down‐regulation has been suggested as the first choice treatment for women with endometriosis‐associated infertility (<a href="./references#CD013240-bbs2-0048" title="ESHRE Endometriosis Guideline Development Group. Management of women with endometriosis. Guideline of the European Society of Human Reproduction and Embryology2013. ">ESHRE 2013</a>). However, many clinicians still have doubts about its effectiveness. Concerns include the possibility that it may lower ovarian response to ovarian stimulation, especially among poor responders. The beneficial effects of prolonged GnRH treatment before IVF are seen most often for severe endometriosis, and the benefits and harms of the intervention in mild to moderate disease have not been fully evaluated. Other concerns focus on the unpleasant side effects of GnRH agonist therapy, such as vasomotor and psychological irritability, which may seriously affect women's quality of life. Complications associated with treatment such as infection, pelvic abscess and ovarian hyperstimulation syndrome (OHSS) have not been fully assessed. Alternatively, continuous use of combined oral contraceptives (COCs) (which have the fewest side effects) for six to eight weeks before IVF or ICSI in women with endometriosis has shown favourable fertility outcomes (<a href="./references#CD013240-bbs2-0046" title="deZieglerD , GayetV , AubriotFX , FauqueP , StreuliI , WolfJP , et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcome. Fertility and Sterility2010;94(7):2796‐9. ">de Ziegler 2010</a>), although no comparison with long‐term GnRH treatment has been made. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013240-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013240-sec-0042"></div> <p>To determine the effectiveness and safety of long‐term gonadotrophin‐releasing hormone (GnRH) agonist therapy (minimum 3 months) versus no pretreatment or other pretreatment modalities, such as long‐term continuous combined oral contraception (COC) or surgical therapy of endometrioma, before standard vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) in women with endometriosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013240-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013240-sec-0043"></div> <section id="CD013240-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013240-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included all randomised controlled trials (RCTs) that reported use of any type of GnRH agonist for at least three months before an IVF/ICSI protocol was started in women diagnosed with endometriosis. We included cross‐over trials only if we could extract phase one data. We excluded quasi‐randomised trials. </p> </section> <section id="CD013240-sec-0046"> <h4 class="title">Types of participants</h4> <p>Infertile women diagnosed with endometriosis (regardless of the grade of the disease) and treated with IVF or ICSI. The diagnosis of endometriosis was exclusively based on laparoscopy or laparotomy. For severity of endometriosis, grades according to the American Society of Reproductive Medicine (ASRM) score at laparotomy or laparoscopy were used. </p> </section> <section id="CD013240-sec-0047"> <h4 class="title">Types of interventions</h4> <section id="CD013240-sec-0048"> <h5 class="title">Intervention</h5> <p>Any type of GnRH agonist preparation used to down‐regulate the hypothalamic‐pituitary complex for three months or longer before a standard IVF or ICSI protocol in women diagnosed with endometriosis. </p> </section> <section id="CD013240-sec-0049"> <h5 class="title">Comparison</h5> <p> <ol id="CD013240-list-0001"> <li> <p>Standard IVF/ICSI protocol only</p> </li> <li> <p>Continuous combined oral contraception (COC) therapy for a minimum of six weeks before a standard IVF/ICSI protocol </p> </li> <li> <p>Surgical excision of endometrioma within six months before the start of a standard IVF/ICSI protocol </p> </li> </ol> </p> <p>Studies with a cointervention (e.g. surgical treatment of endometriosis in both groups prior to the study intervention) were eligible for inclusion. </p> </section> </section> <section id="CD013240-sec-0050"> <h4 class="title">Types of outcome measures</h4> <p>We recorded the following outcomes if the information was available.</p> <section id="CD013240-sec-0051"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD013240-list-0002"> <li> <p>Live birth rate: delivery of a live foetus after 22 completed weeks of gestational age </p> </li> <li> <p>Complication rate: adverse effects per woman (e.g. infection, ovarian hyperstimulation syndrome (OHSS), serious vasomotor instability, overall adverse effects) </p> </li> </ol> </p> </section> <section id="CD013240-sec-0052"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013240-list-0003"> <li> <p>Clinical pregnancy rate per couple/woman: defined as pregnancy confirmed by visualisation of a foetal sac on ultrasound (<a href="./references#CD013240-bbs2-0085" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. [DOI: 10.1016/j.fertnstert.2017.06.005] ">Zegers‐Hochschild 2017</a>) </p> </li> <li> <p>Multiple pregnancy rate: number of twin, triplet or higher‐order pregnancies (specified if possible) per pregnancy and confirmed by ultrasound or delivery </p> </li> <li> <p>Miscarriage rate: miscarriage defined as the spontaneous loss of an intrauterine pregnancy prior to 22 completed weeks of gestational age (<a href="./references#CD013240-bbs2-0085" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. [DOI: 10.1016/j.fertnstert.2017.06.005] ">Zegers‐Hochschild 2017</a>) </p> </li> <li> <p>Ectopic pregnancy rate: ectopic pregnancy defined as a pregnancy outside the uterine cavity, diagnosed by ultrasound, surgical visualisation or histopathology, per couple/woman (<a href="./references#CD013240-bbs2-0085" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. [DOI: 10.1016/j.fertnstert.2017.06.005] ">Zegers‐Hochschild 2017</a>) </p> </li> <li> <p>Foetal abnormalities: number of women giving birth to a child with a foetal abnormality</p> </li> <li> <p>Mean number of oocytes retrieved per woman</p> </li> <li> <p>Mean number of embryos obtained per woman</p> </li> </ol> </p> </section> </section> </section> <section id="CD013240-sec-0053"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all published and unpublished randomised controlled trials (RCTs) of women diagnosed with endometriosis and treated with GnRH agonists to down‐regulate the hypothalamic‐pituitary complex before IVF or ICSI, without language restriction and in consultation with the Cochrane Gynaecology and Fertility (CGF) Information Specialist. </p> <section id="CD013240-sec-0054"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases from their inception to 8 January 2019.</p> <p> <ol id="CD013240-list-0004"> <li> <p>The CGF Specialised Register of Controlled Trials; searched 8 January 2019 (PROCITE platform) (<a href="./appendices#CD013240-sec-0124">Appendix 1</a>). </p> </li> <li> <p>CENTRAL via the Cochrane CENTRAL Register of Studies ONLINE (CRSO); searched 8 January 2019 (Web platform) (<a href="./appendices#CD013240-sec-0125">Appendix 2</a>). </p> </li> <li> <p>MEDLINE; searched from 1946 to 8 January 2019 (OVID platform) (<a href="./appendices#CD013240-sec-0126">Appendix 3</a>). </p> </li> <li> <p>Embase; searched from 1980 to 8 January 2019 (OVID platform) (<a href="./appendices#CD013240-sec-0127">Appendix 4</a>). </p> </li> <li> <p>PsycINFO; searched from 1806 to 8 January 2019 (OVID platform) (<a href="./appendices#CD013240-sec-0128">Appendix 5</a>). </p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL); searched from 1961 to 8 January 2019 (EBSCO platform) (<a href="./appendices#CD013240-sec-0129">Appendix 6</a>). </p> </li> </ol> </p> <p>We combined the MEDLINE search with the Cochrane highly sensitive search strategy for identifying randomised trials, which appears in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013240-bbs2-0061" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Chichester (UK): John Wiley &amp; Sons, 95‐150. ">Lefebvre 2008</a>). EMBASE, PsycINFO and CINAHL searches were combined with trial filters developed by the Scottish Intercollegiate Guidelines Network (<a href="http://SIGN; http://www.sign.ac.uk/methodology/filters.html#random" target="_blank">www.sign.ac.uk/methodology/filters</a>). </p> <p>Other electronic sources of trials included the following.</p> <p> <ol id="CD013240-list-0005"> <li> <p>Trial registers for ongoing and registered trials.</p> <ol id="CD013240-list-0006"> <li> <p>ClinicalTrials.gov; a service of the US National Institutes of Health (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>World Health Organization International Trials Registry Platform search portal (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch</a>). </p> </li> </ol> </li> <li> <p>DARE (Database of Abstracts of Reviews of Effects) in <i>the Cochrane Library</i> at <a href="http://onlinelibrary.wiley.com/o/cochrane/cochrane_cldare_articles_fs.html" target="_blank">onlinelibrary.wiley.com</a> (for reference lists from relevant non‐Cochrane reviews). </p> </li> <li> <p>Web of Knowledge; another source of trials and conference abstracts (<a href="http://wokinfo.com/" target="_blank">wokinfo.com</a>). </p> </li> <li> <p>OpenGrey; for unpublished literature from Europe (<a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu</a>). </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information Database; for trials from the Portuguese and Spanish speaking world; <a href="http://regional.bvsalud.org/php/index.php?lang=en)" target="_blank">regional.bvsalud.org</a>). </p> </li> <li> <p>PubMed and Google (for recent trials not yet indexed in MEDLINE).</p> </li> </ol> </p> </section> <section id="CD013240-sec-0055"> <h4 class="title">Searching other resources</h4> <p>We handsearched reference lists of articles retrieved by the search and contacted experts in the field to obtain additional data. We also handsearched relevant journals and conference abstracts that are not covered in the CGF register, in liaison with the Information Specialist. </p> </section> </section> <section id="CD013240-sec-0056"> <h3 class="title" id="CD013240-sec-0056">Data collection and analysis</h3> <section id="CD013240-sec-0057"> <h4 class="title">Selection of studies</h4> <p>Two review authors (EG and PM) carried out an initial screen of titles and abstracts retrieved by the search and identified potentially eligible studies. The full texts of these studies were retrieved. Two review authors (EG and PM or PB) independently examined these full‐text articles for compliance with the inclusion criteria and selected studies eligible for inclusion in the review. We corresponded with study investigators as required to clarify study eligibility. Disagreements as to study eligibility were resolved by discussion or by discussion with a third review author (IG). The selection process was documented with a PRISMA flow chart (<a href="./references#CD013240-bbs2-0066" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta‐Analyses: The PRISMA Statement.. PLOS Medicine2009;6(7):e1000097. [DOI: doi:10.1371/journal.pmed1000097] ">Moher 2009</a>). </p> </section> <section id="CD013240-sec-0058"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (EG and PM or PB) independently extracted data from eligible studies. Any discrepancies were resolved by discussion or by discussion with a third review author (IG). If a study appeared to meet the eligibility criteria but had aspects of methodology that were unclear, or if the data were provided in a form that was unsuitable for meta‐analysis, the study authors were contacted, and additional information on trial methodology or actual original trial data, or both, was sought. When studies had multiple publications, the review authors collated all reports of the same study, so that each study rather than each report was the unit of interest in the review, and such studies were given a single study ID. </p> </section> <section id="CD013240-sec-0059"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (EG and PM or PB) independently assessed the included studies for risk of bias using the Cochrane 'Risk of bias' assessment tool (<a href="./references#CD013240-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration: Available from handbook.cochrane.org. ">Higgins 2011</a>) to assess allocation (random sequence generation and allocation concealment); blinding of participants and personnel; blinding of outcome assessors; incomplete outcome data; selective reporting and other bias. Disagreements were resolved by discussion or by discussion with a third review author (IG). We fully described all judgements and presented the conclusions in the 'Risk of bias' table, which was incorporated into the interpretation of review findings by means of sensitivity analyses. </p> <p>We took care to search for within‐trial selective reporting, such as trials failing to report obvious outcomes or reporting them in insufficient detail to allow inclusion. We sought published protocols and compared outcomes between the protocol and the final published study. </p> </section> <section id="CD013240-sec-0060"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. live birth rate) we used the numbers of events in the control and intervention groups of each study to calculate risk ratios (RRs). For continuous data we calculated mean differences (MDs) between treatment groups. We present 95% confidence intervals (CIs) for all outcomes. If appropriate, we used number needed to treat for an additional beneficial outcome (NNTB), number needed to treat for an additional harmful outcome (NNTH), or both, to describe significant findings. </p> </section> <section id="CD013240-sec-0061"> <h4 class="title">Unit of analysis issues</h4> <p>The primary analysis was per woman randomised. A sensitivity analysis using per pregnancy data was also included for relevant outcomes (multiple pregnancy, miscarriage, ectopic pregnancy, foetal abnormalities). We planned to briefly summarise in an additional table data that did not allow valid analysis (e.g. 'per cycle' or 'per embryo' data), and these were not meta‐analysed. </p> <p>If studies reported only 'per cycle' data, we contacted study authors to request 'per woman randomised' data. </p> <p>We counted multiple live births (e.g. twins, triplets) as one live birth event.</p> </section> <section id="CD013240-sec-0062"> <h4 class="title">Dealing with missing data</h4> <p>We analysed the data on an intention‐to‐treat basis as far as possible and made attempts to obtain missing data from the original trialists. When data on live birth or clinical pregnancy could not be obtained, we assumed that the outcome did not occur. For other outcomes, we analysed only available data. </p> </section> <section id="CD013240-sec-0063"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether clinical and methodological characteristics of the included studies were sufficiently similar for meta‐analysis to provide a clinically meaningful summary. We assessed statistical heterogeneity by measuring the I<sup>2</sup> statistic. We considered an I<sup>2</sup> measurement greater than 50% to indicate substantial heterogeneity (<a href="./references#CD013240-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration: Available from handbook.cochrane.org. ">Higgins 2011</a>). Where substantial heterogeneity was detected, we explored possible explanations in sensitivity analyses (see below) and considered a subgroup analysis. We took any statistical heterogeneity into account when interpreting the results, especially if variation in the direction of effect was noted. </p> </section> <section id="CD013240-sec-0064"> <h4 class="title">Assessment of reporting biases</h4> <p>The review authors aimed to minimise the potential impact of publication bias and other reporting biases by ensuring a comprehensive search for eligible studies. If 10 or more studies were included in an analysis, we planned to use a funnel plot to explore the possibility of small‐study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies; <a href="./references#CD013240-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration: Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD013240-sec-0065"> <h4 class="title">Data synthesis</h4> <p>Where studies were sufficiently similar, we combined the data using a fixed‐effect model in the following comparisons. </p> <p> <ol id="CD013240-list-0007"> <li> <p>Long‐term GnRH agonist pretreatment followed by standard IVF/ICSI versus standard IVF/ICSI only. </p> </li> <li> <p>Long‐term GnRH agonist pretreatment versus at least six weeks of COC pretreatment, both followed by standard IVF/ICSI. </p> </li> <li> <p>Long‐term GnRH agonist treatment versus surgical excision of endometriomas, both followed by standard IVF/ICSI. </p> </li> </ol> </p> <p>Analyses were stratified by months of GnRH agonist pretreatment: three months, six months, over six months. </p> <p>We displayed an increase in the risk of a particular outcome which may be beneficial (e.g. live birth) or detrimental (e.g. adverse effects) graphically in the meta‐analyses to the right of the centre line, and a decrease in the odds of an outcome to the left of the centre line. </p> </section> <section id="CD013240-sec-0066"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where data were available, we conducted subgroup analyses to determine separate evidence within the following subgroups. </p> <p> <ol id="CD013240-list-0008"> <li> <p>Severity of endometriosis; stage I/II and stage III/IV disease.</p> </li> <li> <p>Previous history of surgery to treat endometriosis.</p> </li> <li> <p>Type of embryo transfer: fresh or cryopreserved.</p> </li> </ol> </p> </section> <section id="CD013240-sec-0067"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses for the primary outcome measures to determine whether the conclusions were robust to arbitrary decisions made regarding eligibility and analysis. These analyses included consideration of whether the review conclusions would have differed if: </p> <p> <ol id="CD013240-list-0009"> <li> <p>eligibility had been restricted to studies at low risk of bias (i.e. no high risk of selection bias); </p> </li> <li> <p>the effect measure had been expressed as odds ratio (OR) rather than RR;</p> </li> <li> <p>the unit of analysis had been per pregnancy rather than per woman, for relevant outcomes (multiple pregnancy, miscarriage, ectopic pregnancy, foetal abnormalities). </p> </li> </ol> </p> <p>Where substantial heterogeneity was detected, we explored clinical or methodological differences between studies that might have accounted for the heterogeneity. </p> <section id="CD013240-sec-0068"> <h5 class="title">Overall quality of the body of evidence: 'Summary of findings' table</h5> <p>We generated a 'Summary of findings' table using GRADEpro software (<a href="./references#CD013240-bbs2-0053" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 28 October 2019. Hamilton (ON): McMaster University (developed by Evidence Prime). ">GRADEpro GDT 2015</a>). This table was prepared by two review authors (EG and PM) working independently, with disagreements resolved by consensus. It evaluates the overall quality of the body of evidence for the main review comparison (GnRH agonist pretreatment versus no pretreatment) and reports the main review outcomes (live birth rate, complication rate, clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, mean number of oocytes, and mean number of embryos), using GRADE criteria (study limitations (i.e. risk of bias), consistency of effect, imprecision, indirectness and publication bias). We have justified, documented and incorporated into the report of results for each outcome our judgements about evidence quality (high, moderate, low or very low). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013240-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013240-sec-0069"></div> <section id="CD013240-sec-0070"> <h3 class="title">Description of studies</h3> <section id="CD013240-sec-0071"> <h4 class="title">Results of the search</h4> <p>We ran the updated electronic search on 8 January 2019, and this yielded 817 articles. We identified 59 additional articles via other sources: 23 via ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) and 36 via the World Health Organization International Trials Registry Platform search portal (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch</a>). After removal of duplicates, 809 were left for screening. Of these, we excluded 770 as they were clearly not relevant. We reviewed 39 full‐text articles of which we excluded 27 (<a href="./references#CD013240-sec-0139" title="">Characteristics of excluded studies</a>). One study is awaiting classification as it was not clear how endometriomas were diagnosed (<a href="./references#CD013240-sec-0140" title="">Characteristics of studies awaiting classification</a>), and two studies were ongoing trials that had not yet reported their results (<a href="./references#CD013240-sec-0141" title="">Characteristics of ongoing studies</a>). </p> <p>We identified eight studies (nine articles) that met the inclusion criteria for this review (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). Of these, we included two in our qualitative analysis (<a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), and six in our quantitative analysis (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). We have presented the trial flow diagram in <a href="#CD013240-fig-0001">Figure 1</a>. The previous <a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a> version of this review incorporated <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>, <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a> and <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>. </p> <div class="figure" id="CD013240-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013240-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013240-sec-0072"> <h4 class="title">Included studies</h4> <section id="CD013240-sec-0073"> <h5 class="title">Study design and setting</h5> <p>We included eight parallel‐design randomised controlled trials (RCTs), five of which have been published as full articles (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), one was published as a conference abstract (<a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), and two are unpublished studies (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). Five studies were single‐centre (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), one study was multiple‐centre (<a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>), and for two studies it was unclear (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). Two of the studies were carried out in the USA (<a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), and one each in Belgium (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>), Germany (<a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>), Greece (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>), Israel (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>), Italy (<a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), and Spain (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). </p> </section> <section id="CD013240-sec-0074"> <h5 class="title">Participants</h5> <p>The eight included studies had a total of 640 participants: 322 women in the intervention group and 318 in the control group. All included patients had a diagnosis of endometriosis at laparoscopy or laparotomy. <a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a> and <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a> included patients with stages I or II endometriosis, <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a> included patients with stages II‐IV endometriosis and <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> included patients with stages III or IV endometriosis. <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a> and <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a> included patients with any severity of endometriosis. <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a> described endometriosis as severe and <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a> included patients with laparoscopically diagnosed endometriosis but "no current sonographic evidence of an ovarian endometrioma &gt; 2 cm in mean diameter". </p> <p>The mean age of participants ranged from 30.3 to 33.9 years, where reported (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>). <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a> reported that the age range in their study was 23 to 40 years old and <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> did not comment on age. In five studies, patients underwent in vitro fertilisation (IVF) (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), in two studies they had IVF or intracytoplasmic sperm injection (ICSI) (<a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>), and in one study it was not clear which type of assisted reproductive technique was employed (<a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). </p> </section> <section id="CD013240-sec-0075"> <h5 class="title">Interventions</h5> <p>Surgical treatment of endometriosis was performed prior to randomisation in five studies (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>), whereas in three studies it was not clear whether any treatment was performed (<a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). </p> <p>Three studies used leuprolide (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), two studies used goserelin (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>), two studies used triptorelin (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), and one used decapeptyl (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>). Duration of treatment was for three months in five studies (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), six months in two studies (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), and five to six months in one study (<a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>). </p> <p>For all included studies, the control group consisted of standard IVF/ICSI (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). None of the studies had control groups including the control group of continuous combined oral contraception (COC) therapy for a minimum of six weeks before standard IVF/ICSI or surgical excision of endometrioma within six months before the start of standard IVF/ICSI. </p> </section> <section id="CD013240-sec-0076"> <h5 class="title">Outcomes</h5> <section id="CD013240-sec-0077"> <h6 class="title">Primary outcomes</h6> <p>One study reported on the primary outcome of live birth (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). Three studies reported on the primary outcome of complication rate (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>); specifically ovarian hyperstimulation syndrome (OHSS) (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>), local reaction at injection site (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>), and premature luteinisation (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>). </p> </section> <section id="CD013240-sec-0078"> <h6 class="title">Secondary outcomes</h6> <p>Eight studies reported on clinical pregnancy rate (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), and of these, six could be included for meta‐analysis (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). The reasons for exclusion of <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a> and <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> are detailed in <a href="./references#CD013240-sec-0138" title="">Characteristics of included studies</a>. </p> <p>Two studies reported on multiple pregnancy rate (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), two studies reported on miscarriage rate (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), two studies reported on ectopic pregnancy rate (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>), and two studies reported on foetal abnormality rate (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). </p> <p>Six studies reported on the mean number of oocytes (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), of which four could be included for meta‐analysis as per woman data (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). The reasons for exclusion of <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a> and <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> are detailed in <a href="./references#CD013240-sec-0138" title="">Characteristics of included studies</a>. </p> <p>Two studies reported on the mean number of embryos obtained per woman (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). </p> </section> </section> <section id="CD013240-sec-0079"> <h5 class="title">Author correspondence</h5> <p>We contacted the authors of <a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>, <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>, <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>, <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>, <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a> and <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> to obtain and clarify data. To date, we have received a response from <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a> and <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>. </p> </section> </section> <section id="CD013240-sec-0080"> <h4 class="title">Excluded studies</h4> <p>We excluded 27 studies for the following reasons.</p> <p> <ul id="CD013240-list-0010"> <li> <p>14 wrong study design</p> </li> <li> <p>1 duplicate study</p> </li> <li> <p>6 no IVF/ICSI in either group</p> </li> <li> <p>2 sub‐studies of already included patient population</p> </li> <li> <p>2 wrong comparator</p> </li> <li> <p>1 wrong intervention</p> </li> <li> <p>1 wrong patient population</p> </li> </ul> </p> </section> </section> <section id="CD013240-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed risk of bias in all included studies as demonstrated in <a href="#CD013240-fig-0002">Figure 2</a> and <a href="#CD013240-fig-0003">Figure 3</a>. Detailed information can be found in <a href="./references#CD013240-sec-0138" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD013240-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013240-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013240-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013240-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013240-sec-0082"> <h4 class="title">Allocation</h4> <section id="CD013240-sec-0083"> <h5 class="title">Random sequence generation</h5> <p>Seven studies utilised adequate methods for random sequence generation, such as computer‐generated random number tables, and hence we deemed them to be at low risk of bias (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a> states that patients were "randomly and sequentially allocated" and attempts to contact the study authors at the time of the previous version of this review (<a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>), were unsuccessful. </p> </section> <section id="CD013240-sec-0084"> <h5 class="title">Allocation concealment</h5> <p>One study reported an adequate method of allocation concealment using "opaque‐sealed envelopes, sequentially numbered' and hence we deemed it to be at low risk of bias (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). Four studies provided no details of allocation concealment and hence we deemed them to be at unclear risk of bias (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). We also judged <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a> to be at unclear risk of bias, based on patients being "randomly and sequentially allocated", as was <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>, in which the random allocation was made by the first author. In correspondence with <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>, they confirmed that no allocation concealment was undertaken and hence we labelled the study as high risk of bias. </p> </section> </section> <section id="CD013240-sec-0085"> <h4 class="title">Blinding</h4> <section id="CD013240-sec-0086"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>One study confirmed blinding of participants and personnel and hence we judged it to be at low risk of bias (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). Four studies reported being open label (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), and the previous version of this review (<a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>), mentions no placebo injections in another two studies (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>); we judged all of these to be at high risk of bias. One study did not report on blinding and we labelled it as unclear risk of bias (<a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). </p> </section> <section id="CD013240-sec-0087"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>We judged <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a> to be at low risk of bias, as blinding was maintained during the study until follow‐up was completed. We judged most other studies to be at high risk as they were open label (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>), or previously reported no blinding (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a> and <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a> in <a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>). We labelled <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> as unclear risk of bias as no information was supplied. </p> </section> </section> <section id="CD013240-sec-0088"> <h4 class="title">Incomplete outcome data</h4> <p>An intention‐to‐treat analysis was performed in two studies (<a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>), and hence we judged them to be at low risk of bias. For <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>, a lack of study dropouts was confirmed in author correspondence at the time of the previous version of this review (<a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>). We marked four studies at high risk of bias in light of a lack of an intention‐to‐treat analysis (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>). Where data were available, we used the number of participants randomised for this meta‐analysis (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). Where the data for meta‐analysis were not available, we included the study in the qualitative synthesis (<a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>). We judged one study to be at unclear risk of bias as no information was supplied (<a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). </p> </section> <section id="CD013240-sec-0089"> <h4 class="title">Selective reporting</h4> <p>We deemed all studies to be at low risk of bias as they all reported on a priori outcomes (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). We did, however, note that in one study, there was a change in the secondary outcomes (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>), and in another study there was a change in the primary outcome (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). </p> </section> <section id="CD013240-sec-0090"> <h4 class="title">Other potential sources of bias</h4> <p>We deemed one study to be at low risk of bias on the basis of no difference in basal patient characteristics and no conflict of interest or relevant funding sources (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>). We judged two studies to be at unclear risk of bias on the basis of a lack of information on conflict of interest or funding sources (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>). We labelled five studies as high risk of bias; three due to the fact that they all received funding from pharmaceutical companies involved in making GnRH analogues (<a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>); and two due to the fact that they are presently unpublished plus lack information on conflict of interest and funding sources (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). In addition, in one study there was a higher proportion of stage III or IV endometriosis in the intervention arm than the control arm (<a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). </p> </section> </section> <section id="CD013240-sec-0091"> <h3 class="title" id="CD013240-sec-0091">Effects of interventions</h3> <p>See: <a href="./full#CD013240-tbl-0001"><b>Summary of findings for the main comparison</b> Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI)</a> </p> <p>See: <a href="./full#CD013240-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD013240-sec-0092"> <h4 class="title">1. Comparison of gonadotrophin‐releasing hormone (GnRH) agonist to standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) protocol only </h4> <section id="CD013240-sec-0093"> <h5 class="title">Primary outcomes</h5> <section id="CD013240-sec-0094"> <h6 class="title">1.1 Live birth rate</h6> <p>We are uncertain whether long‐term GnRH agonist therapy affects the live birth rate compared to standard IVF/ICSI (risk ratio (RR) 0.48, 95% confidence interval (CI) 0.26 to 0.87; 1 RCT, n = 147; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0007" title="">Analysis 1.1</a>; <a href="#CD013240-fig-0004">Figure 4</a>). This suggests that with a live birth rate of approximately 36% (355 per 1000) with standard IVF/ICSI, the equivalent live birth rate with long‐term GnRH agonist therapy prior to standard IVF/ICSI lies between 9% and 31% (92 to 309 per 1000). </p> <div class="figure" id="CD013240-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.1 Live birth rate." data-id="CD013240-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.1 Live birth rate. </p> </div> </div> </div> <p>We did not perform sensitivity analysis as only one unpublished trial reported on the primary outcome of live birth. </p> <section id="CD013240-sec-0095"> <p><b>1.1.1 Subgroup analysis: severity of endometriosis</b></p> <p>We are uncertain whether long‐term GnRH agonist therapy affects the live birth rate compared to standard IVF/ICSI in patients with either stage I/II endometriosis (Peto OR 0.16, 95% CI 0.03 to 0.83; 1 RCT, n = 33; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0021" title="">Analysis 1.15</a>) or stage III/IV endometriosis . (Peto OR 0.49, 95% CI 0.22 to 1.10; 1 RCT, n = 114; I<sup>2</sup> not calculable; low‐quality evidence; <a href="./references#CD013240-fig-0022" title="">Analysis 1.16</a>). </p> </section> <section id="CD013240-sec-0096"> <p><b>Subgroup analysis: previous history of surgery to treat endometriosis</b></p> <p>None of the included studies reported on this comparison.</p> </section> <section id="CD013240-sec-0097"> <p><b>Subgroup analysis: type of embryo transfer</b></p> <p>None of the included studies reported on this comparison.</p> </section> </section> <section id="CD013240-sec-0098"> <h6 class="title">1.2 Complication rate</h6> <p>We are uncertain whether long‐term GnRH agonist therapy affects the overall complication rate (Peto OR 1.23, 95% CI 0.37 to 4.14; 3 RCTs, n = 318; I<sup>2</sup> = 73%; very low‐quality evidence; <a href="./references#CD013240-fig-0016" title="">Analysis 1.10</a>). This suggests that with a complication rate of approximately 3% (31 per 1000) with standard IVF/ICSI, the equivalent complication rate with long‐term GnRH agonist therapy prior to IVF/ICSI lies between 1% and 13% (11 to 128 per 1000). </p> <p>We did not perform sensitivity analysis as data for this outcome originated exclusively from unpublished trials. Looking at specific complications following long‐term GnRH agonist therapy, we are uncertain whether this intervention affects the incidence of ovarian hyperstimulation syndrome (OHSS) (Peto OR 0.75, 95% CI 0.17 to 3.40; 2 RCTs, n = 267; I<sup>2</sup> = 39%; very low‐quality evidence), local reaction at the injection site (Peto OR 8.04, 95% CI 0.50 to 130.02; 1 RCT, n = 147; I<sup>2</sup> not calculable; very low‐quality evidence) or premature luteinisation (Peto OR 1.00, 95% CI 0.06 to 16.18; 1 RCT, n = 120; I<sup>2</sup> not calculable; very low‐quality evidence). See <a href="./references#CD013240-fig-0008" title="">Analysis 1.2</a> and <a href="#CD013240-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD013240-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.2 Complication rate." data-id="CD013240-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.2 Complication rate. </p> </div> </div> </div> <section id="CD013240-sec-0099"> <p><b>1.2.1 Subgroup analysis: severity of endometriosis</b></p> <p>We are uncertain whether long‐term GnRH agonist treatment affects the complication rate compared to standard IVF/ICSI in patients with stage I/II endometriosis (no events in either group, see <a href="./references#CD013240-fig-0023" title="">Analysis 1.17</a>) or stage III/IV endometriosis (Peto OR 0.14, 95% CI 0.01 to 1.42; 1 RCT, n = 114; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0024" title="">Analysis 1.18</a>). </p> </section> <section id="CD013240-sec-0100"> <p><b>1.2.2 Subgroup analysis: previous history of surgery to treat endometriosis</b></p> <p>None of the included studies reported on this comparison.</p> </section> <section id="CD013240-sec-0101"> <p><b>1.2.3 Subgroup analysis: type of embryo transfer</b></p> <p>None of the included studies reported on this comparison.</p> </section> </section> </section> <section id="CD013240-sec-0102"> <h5 class="title">Secondary outcomes</h5> <section id="CD013240-sec-0103"> <h6 class="title">1.3 Clinical pregnancy rate</h6> <p>We are uncertain of the effect of long‐term GnRH agonist therapy on clinical pregnancy rate (RR 1.13, 95% CI 0.91 to 1.41; six RCTs, n = 552; I<sup>2</sup> = 66%; very low‐quality evidence; <a href="./references#CD013240-fig-0009" title="">Analysis 1.3</a>; <a href="#CD013240-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD013240-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 GnRH agonist therapy vs Standard IVF/ICSI alone, outcome: 1.3 Clinical Pregnancy Rate." data-id="CD013240-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 GnRH agonist therapy vs Standard IVF/ICSI alone, outcome: 1.3 Clinical Pregnancy Rate. </p> </div> </div> </div> <p>Due to the high degree of heterogeneity, we repeated the analysis using a random‐effects model yielding similar results (RR 1.20, 95% CI 0.81 to 1.78; six RCTs, n = 552; I<sup>2</sup> = 66%; very low‐quality evidence). </p> <p>We could not include data from two studies in the meta‐analysis and we have summarised these in <a href="#CD013240-tbl-0002">Table 1</a> and explained the reasons for this in <a href="./references#CD013240-sec-0138" title="">Characteristics of included studies</a>. </p> <div class="table" id="CD013240-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Data not suitable for meta‐analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean number of oocytes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GnRH agonist therapy: 9* out of 18</p> <p>Standard IVF/ICSI: 9* out of 19</p> <p>* these numbers are approximate, based on calculations done using % and assumption on number of patients per group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GnRH agonist therapy (mean + SD): 10.3* + 7.19*</p> <p>Standard IVF/ICSI (mean + SD): 18* + 13.76*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GnRH agonist therapy: 7 out of 29</p> <p>Standard IVF/ICSI: 7 out of 32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GnRH agonist therapy: 4.3 + 2.5^</p> <p>Standard IVF/ICSI: 5.4 + 4.7^</p> <p>^: unclear if SD</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>GnRH</b> : gonadotrophin‐releasing hormone; <b>IVF/ICSI</b> : in vitro fertilisation/intracytoplasmic sperm injection; <b>SD</b>: standard deviation </p> </div> </div> </section> <section id="CD013240-sec-0104"> <h6 class="title">1.4. Multiple pregnancy rate</h6> <p>We are uncertain whether long‐term GnRH agonist therapy affects the multiple pregnancy rate per woman randomised (Peto OR 0.14, 95% CI 0.03 to 0.56; 2 RCTs, n = 208; I<sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#CD013240-fig-0010" title="">Analysis 1.4</a>). Similar results are obtained if the multiple pregnancy rate is expressed per clinical pregnancy (Peto OR 0.17, 95% CI 0.03 to 1.05; 1 RCT, n = 147; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0017" title="">Analysis 1.11</a>). </p> </section> <section id="CD013240-sec-0105"> <h6 class="title">1.5 Miscarriage rate</h6> <p>We are uncertain of the effect of long‐term GnRH agonist therapy on the miscarriage rate (Peto OR 0.45, 95% CI 0.10 to 2.00; 2 RCTs, n = 208; I<sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#CD013240-fig-0011" title="">Analysis 1.5</a>). Similar results are obtained if the miscarriage rate is expressed per clinical pregnancy (Peto OR 0.93, 95% CI 0.15 to 5.54; 1 RCTs, n = 57; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0018" title="">Analysis 1.12</a>). </p> </section> <section id="CD013240-sec-0106"> <h6 class="title">1.6 Ectopic pregnancy rate</h6> <p>We are uncertain of the effect of long‐term GnRH agonist therapy on the ectopic pregnancy rate (Peto OR 0.14, 95% CI 0.00 to 7.30; 2 RCTs, n = 198; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0012" title="">Analysis 1.6</a>). </p> <p>Similar results are obtained if the ectopic pregnancy rate is expressed per clinical pregnancy (Peto OR 0.22, 95% CI 0.00 to 13.15; 2 RCTs, n = 198; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0019" title="">Analysis 1.13</a>). </p> </section> <section id="CD013240-sec-0107"> <h6 class="title">1.7 Foetal abnormality rate</h6> <p>We are uncertain of the effect of long‐term GnRH agonist therapy on the foetal abnormality rate (Peto OR 7.93, 95% CI 0.16 to 400.46; 2 RCTs, n = 198; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0013" title="">Analysis 1.7</a>). </p> <p>Similar results are obtained if the foetal abnormality rate is expressed per clinical pregnancy (Peto OR 17.58, 95% CI 0.29 to 1073.88; 2 RCTs, n = 198; I<sup>2</sup> not calculable; very low‐quality evidence; <a href="./references#CD013240-fig-0020" title="">Analysis 1.14</a>). </p> </section> <section id="CD013240-sec-0108"> <h6 class="title">1.8 Mean number of oocytes</h6> <p>We are uncertain of the effect of long‐term GnRH agonist therapy on the mean number of oocytes (mean difference (MD) 0.72, 95% CI 0.06 to 1.38; 4 RCTs, n = 385; I<sup>2</sup> = 81%; very low‐quality evidence; <a href="./references#CD013240-fig-0014" title="">Analysis 1.8</a>). </p> <p>Due to the high degree of heterogeneity, we repeated the analysis using a random‐effects model yielding similar results (MD 0.42, 95% CI ‐1.38 to 2.22; 4 RCTs, n = 385; I<sup>2</sup> = 81%; very low‐quality evidence). </p> <p>We could not include data from two studies in the meta‐analysis and we have summarised these in <a href="#CD013240-tbl-0002">Table 1</a> and explained the reasons for this in <a href="./references#CD013240-sec-0138" title="">Characteristics of included studies</a>. </p> </section> <section id="CD013240-sec-0109"> <h6 class="title">1.9 Mean number of embryos</h6> <p>We are uncertain of the effect of long‐term GnRH agonist therapy on the mean number of embryos (MD ‐0.76, 95% CI ‐1.33 to ‐0.19; 2 RCTs, n = 267; I<sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#CD013240-fig-0015" title="">Analysis 1.9</a>). </p> </section> </section> </section> <section id="CD013240-sec-0110"> <h4 class="title">Comparison of GnRH agonist to continuous combined oral contraception (COC) therapy for a minimum of six weeks before a standard IVF/ICSI protocol </h4> <p>No studies reported on this comparison.</p> </section> <section id="CD013240-sec-0111"> <h4 class="title">Comparison of GnRH agonist to surgical excision of endometrioma within six months before the start of a standard IVF/ICSI protocol </h4> <p>No studies reported on this comparison.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013240-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013240-sec-0112"></div> <section id="CD013240-sec-0113"> <h3 class="title" id="CD013240-sec-0113">Summary of main results</h3> <p>This Cochrane Review aimed to determine the effectiveness and safety of long‐term gonadotrophin‐releasing hormone (GnRH) agonist therapy versus no pretreatment or other pretreatment modalities, specifically long‐term continuous combined oral contraception (COC) or surgical therapy, before standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) in women with endometriosis. Our searches revealed no studies comparing long‐term GnRH agonist therapy to other pretreatment modalities, thus this review has focused entirely on long‐term GnRH agonist therapy versus no pretreatment prior to standard IVF/ICSI. </p> <p>Our findings suggest that there is uncertainty about the effect of long‐term GnRH agonist therapy on the live birth rate compared to standard IVF/ICSI. Subgroup analysis by endometriosis severity further highlighted the uncertainty of the effect of long‐term GnRH agonist therapy on the live birth rate. Subgroup analysis by previous history of surgery to treat endometriosis was not possible due to a lack of data. Subgroup analysis by type of embryo transfer was not possible for the same reason. </p> <p>The quality of the evidence for complication rate was very low and hence it is difficult to draw any conclusion on safety. The data available suggest that the overall complication rate as well as the complication rate by subtype are not associated with any safety concerns with long‐term GnRH agonist therapy. </p> <p>Subgroup analysis by endometriosis severity, similarly had no impact on complication rate. We did not conduct an analysis by months of GnRH agonist pretreatment due to the paucity of data. </p> <p>Very low‐quality evidence leaves us very uncertain on the impact of long‐term GnRH agonist therapy on clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, mean number of oocytes and mean number of embryos. </p> <p>Our findings are summarised in <a href="./full#CD013240-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013240-sec-0114"> <h3 class="title" id="CD013240-sec-0114">Overall completeness and applicability of evidence</h3> <p>Based on our findings, it is evident that there is a paucity of data for the primary outcomes of live birth and complications. Of the included studies, only one reported on the outcome of live birth rate, which of course will be the outcome of most significance to women with endometriosis undertaking fertility treatment (<a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>). Furthermore, this was a relatively small study which at the time of writing of this systematic review was not published and hence had not been through the peer review process. </p> <p>Only three studies looked at complication rate and hence it is difficult to definitively draw conclusions on safety (<a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). We noted a high degree of heterogeneity, and this could be a reflection of the small number of events identified on a background of small studies. </p> <p>The majority of studies focused on clinical pregnancy rate (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>; <a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a>; <a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a>), although only some of these data could be used for meta‐analysis (<a href="./references#CD013240-bbs2-0001" title="DecleerW , OsmanagaogluK , VerschuerenK , ComhaireF , DevroeyP . RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction2016;31(9):2017‐23. ">Decleer 2016</a>; <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>; <a href="./references#CD013240-bbs2-0003" title="NCT01269125 . GnRH‐a and pregnancy rate in in vitro fertilization (IVF) cycles [Ultralong administration of GnRH‐a before in vitro fertilization improves fertilization rate but not pregnancy rate in women with endometriosis. A prospective, randomized, controlled trial]. clinicaltrials.gov/show/NCT01269125 (first received 4 January 2011). ">NCT01269125</a>; <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>; <a href="./references#CD013240-bbs2-0005" title="RickesD , NickelI , KropfS , KleinsteinJ . Increased pregnancy rates after ultralong postoperative therapy with gonadotropin‐releasing hormone analogs in patients with endometriosis. Fertility and Sterility2002 Oct;78(4):757‐62. ">Rickes 2002</a>; <a href="./references#CD013240-bbs2-0006" title="SurreyE , SilverbergK , SurreyM , SchoolcraftW . The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization‐embryo transfer (IVF‐ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial. Fertility and Sterility2001;76(3 Suppl 1):S151. SurreyES , SilverbergKM , SurreyMW , SchoolcraftWB . Effect of prolonged gonadotropin‐releasing hormone agonist therapy on the outcome of in vitro fertilization‐embryo transfer in patients with endometriosis. Fertility and Sterility2002;78(4):699‐704. ">Surrey 2002</a>). Once again, there was no change in this outcome with long‐term GnRH agonist therapy. We noted a significant degree of heterogeneity, mainly due to the contribution of the older study by <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a> and the, as yet, not published study <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>. </p> <p>Similarly, we noted a significant degree of heterogeneity with the mean number of oocytes; once again, this was mainly due to the contribution of the older study by <a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>. We speculate that this could be a reflection of older, outdated IVF protocols and techniques. </p> <p>Overall, even though the findings of the review draw into question the use of long‐term GnRH agonists prior to IVF/ICSI in women with endometriosis, we feel that the overall quality of the evidence is too low to support a move away from the use of GnRH agonists. Further high‐quality research is required to draw definitive conclusions. </p> </section> <section id="CD013240-sec-0115"> <h3 class="title" id="CD013240-sec-0115">Quality of the evidence</h3> <p>In this study we identified and included data originating from eight randomised controlled trials (RCTs), two of which are not published and one which was published solely as an abstract. The total number of participants involved was 640. The risk of bias for individual studies is summarised in <a href="#CD013240-fig-0002">Figure 2</a> and <a href="#CD013240-fig-0003">Figure 3</a>. </p> <p>We rated the quality of the evidence based on the GRADE criteria. The quality of evidence was very low with issues arising due to lack of blinding, imprecision and inconsistency. See <a href="./full#CD013240-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD013240-sec-0116"> <h3 class="title" id="CD013240-sec-0116">Potential biases in the review process</h3> <p>We aimed to reduce the risk of publication bias by conducting systematic searches of multiple databases as well as trial registries to identify unpublished and ongoing studies. We contacted trial authors for (more) information where necessary, although unfortunately data were not always available or we did not receive a response in all cases. It is possible that our searches did not identify all unpublished studies. We performed subgroup analysis by endometriosis severity but data were not available for subgroup analysis by status of previous surgery for endometriosis. As prespecified, where possible, we performed sensitivity analyses on the primary outcomes. We were unable to conduct a funnel plot due to the small number of included studies. </p> </section> <section id="CD013240-sec-0117"> <h3 class="title" id="CD013240-sec-0117">Agreements and disagreements with other studies or reviews</h3> <p>Our review findings are in sharp contrast to the previous version of this review which reported an association between long‐term GnRH agonist therapy and greater live birth and clinical pregnancy rates (<a href="./references#CD013240-bbs2-0087" title="SallamHN , Garcia‐VelascoJA , DiasS , AriciA . Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004635] ">Sallam 2006</a>). Compared to the previous version of this review, the outcome of live birth includes one new RCT in the meta‐analysis and excludes a previously included RCT (<a href="./references#CD013240-bbs2-0002" title="DickerD , GoldmanJA , LevyT , FeldbergD , AshkenaziJ . The impact of long‐term gonadotropin‐releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization‐embryo transfer. Fertility and Sterility1992 Mar;57(3):597‐600. ">Dicker 1992</a>), as this paper does not truly report on live birth as per the <a href="./references#CD013240-bbs2-0085" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. [DOI: 10.1016/j.fertnstert.2017.06.005] ">Zegers‐Hochschild 2017</a> definition. Further, for the outcome of clinical pregnancy rate, this review includes three new RCTs in the meta‐analysis. The net effect of the addition of these RCTs, which in terms of bias are no worse in design, is to bring the results closer to the line of no effect. Indeed, in <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a>, which was the only adequately blinded study to date (i.e. patients in the control group received placebo injections rather than commencing standard IVF/ICSI immediately), both the live birth and clinical pregnancy rates favoured standard IVF/ICSI rather than pretreatment with long‐term GnRH agonists. Given that visible endometriosis was surgically treated in <a href="./references#CD013240-bbs2-0004" title="NCT01581359 . The effect of pre‐treatment with GnRH analogues prior in vitro fertilization in patients with endometriosis (ENDOFIV) [A comparative study, randomized, blinded, about the effect of pre‐treatment with GnRH analogues versus placebo in infertile patients with endometriosis undergoing in vitro fertilization treatment]. clinicaltrials.gov/ct2/show/record/NCT01581359 (first received 20 April 2012). ">NCT01581359</a> prior to randomisation, the argument arises for a potential deleterious effect of long‐term GnRH therapy prior to IVF/ICSI. However, due to the very low quality of this evidence, it is difficult to reach any definitive conclusions at present. The trend for miscarriage rate did not differ from the previous version of this review, whereas in this review we found no trend towards a higher oocyte yield with GnRH agonist therapy. </p> <p>Data from retrospective studies suggest that the live birth and clinical pregnancy rates are improved with cryopreserved embryo transfer after GnRH agonist therapy (<a href="./references#CD013240-bbs2-0065" title="MohamedAM , ChouliarasS , JonesCJ , NardoLG . Live birth rate in fresh and frozen embryo transfer cycles in women with endometriosis. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;156(2):177‐80. ">Mohamed 2011</a>; <a href="./references#CD013240-bbs2-0084" title="XieD , ChenF , XieSZ , ChenZL , TuoP , ZhouR , et al. Artificial cycle with or without a depot gonadotropin‐releasing hormone agonist for frozen‐thawed embryo transfer: an assessment of infertility type that is most suitable. Current Medical Science2018;38(4):626‐31. ">Xie 2018</a>). Due to a lack of data we were unable to examine this outcome in this systematic review. </p> <p>To our knowledge there are no other reviews that address long‐term GnRH agonist therapy compared no or to other pretreatments prior to standard IVF/ICSI. It is worth noting however that at least one other RCT, which did not meet our inclusion criteria and used continuous COC as the control group, also reported no difference in outcomes compared to long‐term GnRH agonist therapy (<a href="./references#CD013240-bbs2-0026" title="NCT02400801 . Gonadotropin‐releasing hormone (GnRH) downregulation versus oral anticonception prior to ART in postoperative endometriosis patients. clinicaltrials.gov/ct2/show/NCT02400801 (first received 27 March 2015). ">NCT02400801</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013240-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013240-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013240-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013240-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.1 Live birth rate." data-id="CD013240-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.1 Live birth rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.2 Complication rate." data-id="CD013240-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 GnRH agonist therapy versus standard IVF/ICSI alone, outcome: 1.2 Complication rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 GnRH agonist therapy vs Standard IVF/ICSI alone, outcome: 1.3 Clinical Pregnancy Rate." data-id="CD013240-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 GnRH agonist therapy vs Standard IVF/ICSI alone, outcome: 1.3 Clinical Pregnancy Rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 1 Live birth rate." data-id="CD013240-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 1 Live birth rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 2 Complication rate." data-id="CD013240-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 2 Complication rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 3 Clinical Pregnancy Rate." data-id="CD013240-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 3 Clinical Pregnancy Rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 4 Multiple pregnancy rate (per woman randomised)." data-id="CD013240-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 4 Multiple pregnancy rate (per woman randomised). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 5 Miscarriage rate (per woman randomised)." data-id="CD013240-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 5 Miscarriage rate (per woman randomised). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 6 Ectopic pregnancy rate (per woman randomised)." data-id="CD013240-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 6 Ectopic pregnancy rate (per woman randomised). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 7 Foetal abnormality rate (per woman randomised)." data-id="CD013240-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 7 Foetal abnormality rate (per woman randomised). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 8 Mean number of oocytes." data-id="CD013240-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 8 Mean number of oocytes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 9 Mean number of embryos." data-id="CD013240-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 9 Mean number of embryos. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 10 Complication rate (totals)." data-id="CD013240-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 10 Complication rate (totals). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 11 Multiple pregnancy rate (per clinical pregnancy)." data-id="CD013240-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 11 Multiple pregnancy rate (per clinical pregnancy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 12 Miscarriage rate (per clinical pregnancy)." data-id="CD013240-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 12 Miscarriage rate (per clinical pregnancy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 13 Ectopic pregnancy (per clinical pregnancy)." data-id="CD013240-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 13 Ectopic pregnancy (per clinical pregnancy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 14 Foetal abnormality rate (per clinical pregnancy)." data-id="CD013240-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 14 Foetal abnormality rate (per clinical pregnancy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 15 Live birth rate (ASRM I/II endometriosis)." data-id="CD013240-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 15 Live birth rate (ASRM I/II endometriosis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 16 Live birth rate (ARSM III/IV endometriosis)." data-id="CD013240-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 16 Live birth rate (ARSM III/IV endometriosis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 17 Complication rate (ARSM I/II endometriosis." data-id="CD013240-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 17 Complication rate (ARSM I/II endometriosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 18 Complication rate (ARSM III/IV endometriosis)." data-id="CD013240-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 18 Complication rate (ARSM III/IV endometriosis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 19 Clinical pregnancy rate (ARSM I/II endometriosis)." data-id="CD013240-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 19 Clinical pregnancy rate (ARSM I/II endometriosis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013240-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/urn:x-wiley:14651858:media:CD013240:CD013240-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_t/tCD013240-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 20 Clinical pregnancy rate (ARSM III/IV endometriosis)." data-id="CD013240-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 GnRH agonist therapy versus standard IVF/ICSI alone, Outcome 20 Clinical pregnancy rate (ARSM III/IV endometriosis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/media/CDSR/CD013240/image_n/nCD013240-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013240-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard IVF/ICSI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with endometriosis prior to standard IVF/ICSI<br/> <b>Setting:</b> assisted reproduction clinic<br/> <b>Intervention:</b> long‐term GnRH agonist therapy<br/> <b>Comparison:</b> no additional therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no additional therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with long‐term GnRH agonist therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.48<br/> (0.26 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>147<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on live birth rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>355 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1000<br/> (92 to 309) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Complication rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Peto OR 1.23<br/> (0.37 to 4.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>318<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on complication rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1000<br/> (11 to 128) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical pregnancy rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/> (0.91 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>552<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on clinical pregnancy rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>331 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>374 per 1000<br/> (301 to 467) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multiple pregnancy rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Peto OR 0.14<br/> (0.04 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>208<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on multiple pregnancy rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (3 to 41) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage rate</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Peto OR 0.45<br/> (0.10 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>208<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>b,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on miscarriage rate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000<br/> (5 to 93) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of oocytes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of oocytes was 8.43</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.72 higher<br/> (0.06 higher to 1.38 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>385<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on mean number of oocytes. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean number of embryos</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of embryos was 4.74</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.76 lower<br/> (1.33 lower to 0.19 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>267<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>c,e,h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of long‐term GnRH agonist therapy on mean number of embryos. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>GnRH</b> : gonadotrophin‐releasing hormone; <b>IVF/ICSI</b> : in vitro fertilisation/intracytoplasmic sperm injection; <b>MD</b> : mean difference; <b>OR:</b> odds ratio; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> data arising exclusively from an unpublished trial; downgraded one level. </p> <p><sup>b</sup> small number of events; downgraded two levels. </p> <p><sup>c</sup> incorporates at least one open‐label study; downgraded one level. </p> <p><sup>d</sup> high degree of heterogeneity; downgraded one level. </p> <p><sup>e</sup> wide confidence intervals; downgraded one level. </p> <p><sup>f</sup> data arising from an unpublished trial and a conference abstract; downgraded one level. </p> <p><sup>g</sup> very high degree of heterogeneity; downgraded two levels. </p> <p><sup>h</sup> significant contribution by an unpublished trial; downgraded one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Long‐term GnRH agonist therapy compared to no additional therapy in patients with endometriosis prior to standard in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013240-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Data not suitable for meta‐analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean number of oocytes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013240-bbs2-0007" title="SurreyES , LietzAK , GustofsonRL , MinjarezDA , SchoolcraftWB . Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertility and Sterility2010;93(2):646‐51. ">Surrey 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GnRH agonist therapy: 9* out of 18</p> <p>Standard IVF/ICSI: 9* out of 19</p> <p>* these numbers are approximate, based on calculations done using % and assumption on number of patients per group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GnRH agonist therapy (mean + SD): 10.3* + 7.19*</p> <p>Standard IVF/ICSI (mean + SD): 18* + 13.76*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013240-bbs2-0008" title="TotaroI , LorussoF , SciosciaM , LorussoM , MangiatordiG , SelvaggiL , et al. IVF outcome after ultralong postoperative therapy with gonadotrophin‐releasing hormone analogs in patients with advanced‐stage endometriosis. Twenty‐fifth meeting of European Society of Human Reproduction and Embryology; 2009 June 28‐July 1; Amsterdam. 2009:i190. ">Totaro 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GnRH agonist therapy: 7 out of 29</p> <p>Standard IVF/ICSI: 7 out of 32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GnRH agonist therapy: 4.3 + 2.5^</p> <p>Standard IVF/ICSI: 5.4 + 4.7^</p> <p>^: unclear if SD</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><b>GnRH</b> : gonadotrophin‐releasing hormone; <b>IVF/ICSI</b> : in vitro fertilisation/intracytoplasmic sperm injection; <b>SD</b>: standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Data not suitable for meta‐analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/full#CD013240-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013240-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">GnRH agonist therapy versus standard IVF/ICSI alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.26, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Complication rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 OHSS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.17, 3.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Local reaction at the injection site</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.04 [0.50, 130.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Premature luteinisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical Pregnancy Rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.91, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Multiple pregnancy rate (per woman randomised) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.03, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Miscarriage rate (per woman randomised) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.10, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Ectopic pregnancy rate (per woman randomised) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.00, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Foetal abnormality rate (per woman randomised) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.93 [0.16, 400.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mean number of oocytes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.06, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mean number of embryos <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.33, ‐0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Complication rate (totals) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.37, 4.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Multiple pregnancy rate (per clinical pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.03, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Miscarriage rate (per clinical pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.15, 5.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Ectopic pregnancy (per clinical pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.00, 13.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Foetal abnormality rate (per clinical pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.58 [0.29, 1073.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Live birth rate (ASRM I/II endometriosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.03, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Live birth rate (ARSM III/IV endometriosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.22, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Complication rate (ARSM I/II endometriosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Complication rate (ARSM III/IV endometriosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Clinical pregnancy rate (ARSM I/II endometriosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.74, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Clinical pregnancy rate (ARSM III/IV endometriosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">GnRH agonist therapy versus standard IVF/ICSI alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013240.pub2/references#CD013240-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013240.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013240-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013240-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013240-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD013240-note-0013">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013240-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD013240-note-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013240-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013240-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013240\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013240\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013240\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013240\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013240\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6iOnQIUh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013240.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013240.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013240.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013240.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013240.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718346308"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013240.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718346312"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013240.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dce1b4f14935f',t:'MTc0MDcxODM0Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 